Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Targeted immunotherapies overtaking emerging oncology market value based growth

Jakovljevic, Mihajlo B LU (2015) In Journal of B.U.ON. 20(1). p.350-351
Please use this url to cite or link to this publication:
author
publishing date
type
Contribution to journal
publication status
published
keywords
Antineoplastic Agents/economics, Budgets, Commerce, Cost Control, Cost-Benefit Analysis, Drug Costs/trends, Drug Industry/economics, Health Expenditures/trends, Health Services Accessibility/economics, Humans, Immunotherapy/economics, Medical Oncology/economics, Molecular Targeted Therapy/economics, Neoplasms/drug therapy, Serbia, Time Factors
in
Journal of B.U.ON.
volume
20
issue
1
pages
350 - 351
publisher
Zerbinis Medical Publ.
external identifiers
  • pmid:25778340
  • scopus:84928701501
ISSN
1107-0625
language
English
LU publication?
no
id
b8955e2f-e0a7-4cbb-84b1-761c4c6baf13
date added to LUP
2018-09-01 22:57:33
date last changed
2024-01-15 00:42:36
@article{b8955e2f-e0a7-4cbb-84b1-761c4c6baf13,
  author       = {{Jakovljevic, Mihajlo B}},
  issn         = {{1107-0625}},
  keywords     = {{Antineoplastic Agents/economics; Budgets; Commerce; Cost Control; Cost-Benefit Analysis; Drug Costs/trends; Drug Industry/economics; Health Expenditures/trends; Health Services Accessibility/economics; Humans; Immunotherapy/economics; Medical Oncology/economics; Molecular Targeted Therapy/economics; Neoplasms/drug therapy; Serbia; Time Factors}},
  language     = {{eng}},
  month        = {{03}},
  number       = {{1}},
  pages        = {{350--351}},
  publisher    = {{Zerbinis Medical Publ.}},
  series       = {{Journal of B.U.ON.}},
  title        = {{Targeted immunotherapies overtaking emerging oncology market value based growth}},
  volume       = {{20}},
  year         = {{2015}},
}